Host adaptation is a key factor contributing to the emergence of new bacterial, viral and parasitic pathogens. Many pathogens are considered promiscuous because they cause disease across a range of host species, while others are host-adapted, infecting particular hosts 1 . Host adaptation can potentially progress to host restriction, where the pathogen is strictly limited to a single host species and is frequently associated with more severe symptoms. Host-adapted and host-restricted bacterial clades evolve from within a broader host-promiscuous species and sometimes target different niches within their specialist hosts, such as adapting from a mucosal to a systemic lifestyle. Genome degradation, marked by gene inactivation and deletion, is a key feature of host adaptation, although the triggers initiating genome degradation are not well understood. Here, we show that a chronic systemic non-typhoidal Salmonella infection in an immunocompromised human patient resulted in genome degradation targeting genes that are expendable for a systemic lifestyle. We present a genome-based investigation of a recurrent blood-borne Salmonella enterica serotype Enteritidis (S. Enteritidis) infection covering 15 years in an interleukin-12 β1 receptor-deficient individual that developed into an asymptomatic chronic infection. The infecting S. Enteritidis harboured a mutation in the mismatch repair gene mutS that accelerated the genomic mutation rate. Phylogenetic analysis and phenotyping of multiple patient isolates provides evidence for a remarkable level of within-host evolution that parallels genome changes present in successful host-restricted bacterial pathogens but never before observed on this timescale. Our analysis identifies common pathways of host adaptation and demonstrates the role that immunocompromised individuals can play in this process.
Host adaptation is central to pathogen evolution and is a founding element in the emergence of many classical and emerging diseases such as typhoid, whooping cough and bubonic plague. For example, typhoid fever is caused by the human-restricted genetic clades Salmonella Typhi and S. Paratyphi A, which evolved independently within the broadly promiscuous Salmonella enterica species. Genome analysis of host-restricted pathogens has linked host adaptation with both gene acquisition and genome degradation 2, 3 . Loss of coding capacity by pseudogene formation or deletion is thought to proceed through a combination of neutral or mildly deleterious mutations becoming fixed in the population during evolutionary bottlenecks and positive selection for the loss of function of genes no longer required or disadvantageous in the new host or environmental niche [3] [4] [5] . S. enterica is a diverse species that harbours both host-promiscuous and host-adapted clades. S. enterica serovars such as Typhimurium and Enteritidis are predominantly associated with gastroenteritis, a disease normally self-limiting to the intestine. However, bacteraemia can occur even with nontyphoidal serovars, and this is frequently associated with malnutrition, human immunodeficiency virus infection, or primary immune deficiencies such as mutations in interleukins (IL)-12 and -23 and their receptors [6] [7] [8] .
In 1995, a 12-year-old patient presented with a clinically severe systemic S. Enteritidis infection and was diagnosed with IL-12 β1 receptor deficiency (homozygous mutation of the IL12RB1 gene) 9 .
Between the ages of 16 and 29 years (1999-2014) , the patient had multiple recurrent systemic S. Enteritidis infections, but the patient reported less severe symptoms with each subsequent episode (Supplementary Discussion). Treatment included interferon-γ (IFNγ) and various antibiotics, including ciprofloxacin, azithromycin and ceftriaxone. Minimum inhibitory concentrations for the antibiotics used in therapy were monitored (Supplementary Table I) .
Analysis of the whole genome sequence of eleven S. Enteritidis isolates from the patient's blood from successive fever episodes revealed that each was due to relapse from the same infection rather than reinfection. A maximum-likelihood tree of the isolates from the immunocompromised patient and seventeen isolates from other patients with standard gastrointestinal S. Enteritidis infections was constructed based on 5,087 single nucleotide polymorphisms (SNPs) with reference to S. Enteritidis phage type 4 (PT4) P125109, excluding SNPs within prophage elements, repetitive sequence and insertion elements (Fig. 1a) . The immunocompromised patient isolates were in a single clade that shared a most-recent common ancestor (MRCA) within the S. Enteritidis PT4 clade. However, the diversity of the immunocompromised patient isolates was much greater than for the main PT4 clade isolates. Isolates within the S. Enteritidis PT4 clade differed from one another by ∼80 SNPs, but the patient isolates differed by as many as 600 SNPs, and the most recent patient isolates contained nearly 1,000 SNPs relative to their MRCA. Accumulation of SNPs along lineages within the patient isolate clade was linear and time-dependent, with a mean of 47 SNPs per genome per year (Fig. 1b) . A timedependent phylogenetic reconstruction using Bayesian inference predicted a time of MRCA (tMRCA) of around 1995 (±0.5 years) (Fig. 1c) . The molecular clock rate was calculated as 1 × 10
SNPs per site per year for the patient lineages, a 25-to 50-fold higher substitution rate than previously reported for Salmonella 10, 11 . Together, these data are consistent with the hypothesis that the patient was infected with a common ancestor that existed around the time of the first detected bacteraemia, and since this time the infecting clone has rapidly acquired mutations.
Within the immunocompromised patient clade there were elevated G→A and C→T nucleotide substitutions ( Supplementary  Fig. 1 ) relative to S. Enteritidis lineages from other patients and there was a region of frequent inversion ( Supplementary Fig. 2) ; both are consistent with a defective mismatch repair mechanism 12 . Indeed, the mutS gene in the patient isolates contained a 174 bp in-frame deletion encoding a truncated protein MutS Δ253-311 . Mutations in mutS have previously been implicated in a 100-fold increase in the transition rate, a 1,000-fold increase in the rate of frameshift mutations, frequent chromosomal rearrangements, and single nucleotide indels in homopolymeric tracts 13, 14 . To determine the contribution of the mutS mutation to the elevated substitution rate of the patient isolates, an identical in-frame deletion was introduced into S. Enteritidis P125109 (SW824 mutS Δ253-311 Fig. 3 ).
Accumulation of SNPs along the branches within the patient clade exhibited a greater dN/dS ratio (where dN/dS is the ratio of nonsynonymous substitutions per nonsynonymous site to the number of synonymous substitutions per synonymous site) compared with branches outside this clade ( Supplementary  Fig. 4 ). The significance of this observation is equivocal and may indicate positive selection of a subset of genes in the genome or may indicate there has been insufficient time for purifying selection to reduce the dN/dS ratio. We could not differentiate between these possibilities because the number of mutations per gene is low and purifying selection requires long time periods to act 15 . We also investigated potential signatures of selection using a profile-based method to predict whether polymorphisms in proteins of the patient isolates were likely to have functionally diverged from P125109. Comparison of orthologous proteins from S. Enteritidis P125109 with patient isolates or with diverse non-patient S. Enteritidis isolates indicated that the patient isolates accumulated more deleterious polymorphisms in conserved protein domains in the pfam database, giving rise to decreased bitscores relative to P125109 ( Supplementary Fig. 5a ,b,). The resulting increase in mean delta bitscore and skew from a normal distribution ( Supplementary Fig. 5c,d ) has been reported in genomes of host-adapted pathogens undergoing genome degradation 16 . To enable us to identify the entire repertoire of hypothetically disrupted genes with a predicted null phenotype (pseudogenes), we constructed single contiguous whole genome sequence assemblies of four patient isolates using the PacBio sequencing platform. Each isolate had acquired, on average, 158 pseudogenes ( disrupted genes and 68 deleted genes already present in S. Enteritidis P125109 17 , this is a degradation of ∼300 genes or ∼6.9% of the total protein coding capacity. This level of genome degradation is comparable to that reported for host-adapted Salmonella serovars (Fig. 2c) .
Although most of the pseudogenes could be readily explained by a single event and were maintained as pseudogenes through successive generations according to the phylogenetic tree, we noticed that some of the pseudogenes showed evidence of reversion, with the functional gene restored in a terminal branch. This occurred in pseudogenes that arose due to frameshifts caused by changes in the length of homopolymeric tracts, a common occurrence in mutS-deficient bacteria 14 . Restoration of the functional gene occurred by one of two mechanisms: deletion of inserted nucleotides or insertion of additional nucleotide(s) that re-established the original reading frame (Supplementary Fig. 6 ). Transient genome degradation akin to this has also been proposed for the humanrestricted pathogen S. Paratyphi A 4 suggesting that this could be a common characteristic of bacteria undergoing adaptation.
Pseudogenes in the patient isolates overlapped with those found in S. Typhi and S. Paratyphi A, with 44 genes disrupted in S. Typhi, S. Paratyphi A and at least one of the four patient isolates analysed (Fig. 2b) . Importantly, the patient isolates have acquired pseudogenes in a large percentage of central anaerobic metabolism, colonization factor and secreted effector genes, three functional classes that promote growth and cellular invasion in the gut and are linked to pathogenesis (Fig. 2d-f ) . Specifically, the nitrate, tetrathionate, ethanolamine and cobalamin vitamin B12 metabolic pathways were degraded in the patient isolates, along with fimbriae and nonfimbrial adhesins, and type three secretion system (T3SS) apparatus and effector proteins (Supplementary Discussion and  Supplementary Tables II and III) . Gene Ontology (GO) enrichment analysis of the pseudogenes also showed over-representation of terms concerned with certain metabolic processes, including cobalamin vitamin B12, membrane proteins and pilus organization genes (Supplementary Table IV) . A number of these GO terms are also over-represented in disrupted genes of S. Typhi and S. Paratyphi A. Thus, the pattern of genome degradation of these host-adapted Salmonellae exhibited considerable overlap with that observed in the patient isolates and represents convergent evolution.
In many cases, the known functions of putatively inactivated genes were consistent with the phenotype and virulence of the patient isolates. The patient isolates harboured SNPs in the quinolone resistance-determining region that were consistent with the elevated minimum inhibitory concentration data for ciprofloxacin in the clinical microbiology data (Supplementary Table I ). Several genes involved in lipopolysaccharide (LPS) biosynthesis, including rfaL, O-antigen ligase and mpl, murein peptide ligase, were pseudogenes in one or more of the patient isolates and may have contributed to the profound changes in cell morphology and sensitivity to serum killing (Supplementary Discussion, Supplementary Table II and Supplementary Figs 7 and 8) . The patient isolates showed aberrant host-pathogen interactions in vitro and in vivo that may be related to observed mutations in adhesins and T3SS proteins. Patient isolates B20062, MB760 and MB4386 were not able to invade the cultured epithelial-like cell line HEp-2 as efficiently as P125109 (Fig. 3a) . The reduction in invasion of patient isolates was even greater than for a defined invA mutation in S. Typhimurium, a key structural component of the SPI-1 T3SS. The cytokine response generated by Salmonella-infected macrophages exhibited a variable and atypical host-cell response to infection by individual patient isolates compared with P125109 ( Supplementary Fig. 9 ). Following oral inoculation of mice, isolate MB4386 was profoundly attenuated compared with P125109. Colonization of the liver and spleen with MB4386 was below the limit of detection in most mice (Fig. 3b) . Following intravenous inoculation, isolate MB4386 was similarly attenuated, with 1,000-to 10,000-fold lower liver and spleen colonization compared Pseudogenes (%) with P125109 (Fig. 3c ) and a higher survival rate. Mice intravenously infected with P125109 were moribund within five days, whereas all mice infected with MB4386 survived beyond day seven (Fig. 3d) . Intriguingly, isolate MB4386 was capable of colonizing and replicating in immunocompromised mice following intravenous inoculation. Indeed, both IL12p40-deficient and IFNγR-deficient mice showed higher levels of colonization with isolate MB4386 following intravenous inoculation ( Supplementary Fig. 10 ). This example of extensive in-host evolution in a single patient recapitulated that observed during the emergence of pathogens of antiquity and the present day. Although most healthy individuals rapidly clear infections and non-typhoidal Salmonella infections are limited to the gut, the extended systemic infection in this patient provided a unique niche for host adaptation. This remarkable clinical case provides insight into the mechanisms driving microbial host adaptation and highlights the potential role of immunocompromised individuals in host adaptation. Exposing a microbe with a gastrointestinal lifestyle to an extra-intestinal niche resulted in genome degradation of specific classes of genes, generating the signature of host adaptation we have defined here. Genes required for persistence in the gut appear to be no longer essential to bacteria residing in an extra-intestinal niche and are probably subject to degradation by the process of genome streamlining. Such a process may be occurring in S. Typhimurium ST313, a genotype associated with invasive non-typhoidal Salmonella (iNTS) disease in immunocompromised populations in subSaharan Africa that has acquired signatures of host adaption in their genome sequence 10, 18 . ST313 and other host-adapted pathogens have retained the ability to transmit to other individuals, a feature that has not necessarily been selected for in this patient. Additionally, the rate of evolution is elevated in this case as the rapid genome degradation in the S. Enteritidis acquired by the patient was driven by a mutS mutation. Reversible mutations to mismatch repair proteins have been implicated previously in Salmonella genome diversification and bacterial adaptation 19 . This study captured a rare opportunity to investigate host adaptation in real time during a single infection. Through an ill-fated 'perfect storm' combining a permissive human host with a hypermutating Salmonella, we were able to observe genome degradation in action as genes and pathways promoting the gastrointestinal lifestyle were lost in an extra-intestinal infection. Crucially, we were able to link the genotypic changes to altered bacterial virulence that drew parallels with the evolution of other host-adapted pathogens including S. Typhi and S. Paratyphi A. Thus, our analysis contributes to our understanding of conserved evolutionary mechanisms underlying the emergence of host-adapted pathogens and highlights the remarkable adaptability of pathogens when they enter a new niche. 
Methods
Bacterial strains and culture conditions. S. ) was engineered (SW824) using a suicide vector-based approach. A region of the MB4386 genome containing the in-frame deletion of mutS was amplified by PCR using primers 5′-ggaAGATCTggataccgggtttatcgg-3′ and 5′-ccgCTCGAGcagtatctcaagctgaaagccc-3′. Restriction enzyme sites BglI and XhoI incorporated into the oligonucleotide primers were used to clone the DNA fragment into the suicide vector pJCB12. The suicide vector construct was introduced into S. Enteritidis strain P125109 by electroporation, and merodiploid derivatives in which the plasmid had integrated into the bacterial chromosome were selected for by culture on LB+Cm agar medium. The merodiploid was resolved by counter selection of levansucrase activity encoded by the sacRB gene on pJCB12, by culture on LB agar containing 5% sucrose. A resolved merodiploid clone containing the deletion was identified by PCR amplification using primers that annealed flanking the deletion.
For in vitro passage of S. Enteritidis ΔmutS and patient isolate B20062, bacteria were serially passaged in 50 ml LB broth incubated for 12 h at 37°C with shaking. Each passage was inoculated with 1 × 10 3 c.f.u. from the previous culture. Cultures from passages 1, 4, 7, 10 and 13 were plated on LB agar plates, and single colonies selected for inoculation of a 50 ml culture of LB broth and incubated for 12 h at 37°C with shaking. Genomic DNA was prepared from this culture and sequenced using the HiSeq Illumina platform.
Genome sequencing and sequence analysis. Multiplex libraries with a 300 bp insert size were prepared using 96 unique index-tags and sequenced to generate 75-basepair (bp) paired-end reads. Cluster formation, primer hybridization and sequencing reactions were based on reversible terminator chemistry using the Illumina HiSeq System. Sequence data were submitted to the European Nucleotide Archive (http://www.ebi.ac.uk/ena; accession numbers are indicated in Supplementary Table V) . For sequence-read alignment and SNP detection, paired-end Illumina sequence data from each isolate were mapped to the reference genome S. Enteritidis strain P125109 (ref. 20) using SMALT (ref. 21). Single nucleotide polymorphisms (SNPs) were identified using samtools mpileup and filtered with a minimum mapping quality of 30 and quality ratio cutoff of 0.75. SNPs identified in prophage elements and repetitive sequence regions of the S. Enteritidis reference were excluded from subsequent phylogenetic analysis. Repetitive regions were defined as exact repetitive sequences of ≥20 bp, identified using the repeat finding programs nucmer (ref. 22) , REPuter (ref. 23 ) and repeat-match (refs 24,25) . A concatenated alignment composed of SNP sites from each sequenced isolate was generated. For phylogenetic analyses, a maximum-likelihood phylogenetic tree was constructed from the SNP alignment with RAxML v7.0.4 (ref. 26) using a general time reversible (GTR) substitution model with gamma correction for among-site rate variation. Support for nodes on the trees was assessed using 100 bootstrap replicates. Raw Illumina HiSeq data were used to generate a de novo draft assembly of the genome of each sample using the VELVET v0.7.03 algorithm 27 , resulting in multi-contig draft genomes. Bayesian ancestral state reconstruction of ten patient isolates from a ten-year period was performed using the BEAST v1.7.5 package 28 . The data for these models were the alignment of variable sites (SNPs) in the genome sequence of the ten patient isolates. A discrete gamma distribution was used to model rate variation among sites, and a strict clock with constant size coalescent tree prior was selected as it required the least parameters. The isolation date in years was used to calibrate the timescale of the tree. Three independent Markov chain Monte Carlo (MCMC) analyses were run, each with a 10 million burn-in and 90 million chain length, sampled every 10,000 states using BEAGLE (ref. 29) in conjunction with BEAST. The maximum clade credibility tree from the resulting 3,600 trees was summarized using TreeAnnotator and visualized with Figtree.
Bitscores were determined for proteins harbouring non-synonymous SNPs using hmmpfam. Delta bitscores were calculated by subtracting the bitscore for a given HMM domain from the bitscore of the orthologous domain in S. Enteritidis P125109. Delta bitscores of zero and those greater than five standard deviations from the mean were removed. Remaining delta bitscores were plotted in a frequency distribution with a window size of 0.5 and skewness and mean values were calculated using excel.
For determination of whole genome sequence for de novo assembly using SMRT PacBio, Template Prep Kit (PacBio) and the BluePippin Size Selection System protocol were used to prepare size-selected libraries (20 kb) from 5 µg of sheared and concentrated DNA. Sequencing was performed using the magnetic bead collection protocol, a 20,000 bp insert size, stage start and 180 min movies. A de novo assembly was generated from these reads using the Hierarchical Genome Assembly Process (HGAP) software version 3.0 (ref. 30), with the genome size parameter set to 5 Mb.
Pseudogenes were identified by in silico determination of annotated features of the draft genome with a decreased length or frameshifts in predicted protein sequence. The annotation was transferred with RATT (ref. 31 ) from the reference onto the new assembly (Parameter PacBio). An ad hoc PERL script compared genes with the transferred annotation to the reference genome and reported frameshifts and changes in length. Pseudogenes were manually confirmed in the aligned genome sequence using the Artemis Comparison Tool (ACT) (ref. 32) . Genes with deletions of over 10% of the coding sequence were classified as pseudogenes. Indels in homopolymeric tracts were verified with Illumina sequencing data. The total number of pseudogenes in the patient isolates was calculated by adding the number of pseudogenes reported by Nuccio and Baumler 17 to the newly identified pseudogenes.
We performed GO enrichment with the R package TopGO (ref. 33 ), using default settings. As databases for the enrichment we downloaded the GO terms for Salmonella Enteritidis P125109 from the GOA database 34 .
Tissue culture, serum sensitivity, cytokine profiling and in vivo infection models. Hep-2 (ECACC #86030501) cells were maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 2 mM L-glutamine and non-essential amino acids and tested for mycoplasma. Cells were not further authenticated. The Hep-2 cell line has been reported to contain HeLa cells, another epithelial cell line commonly used in Salmonella invasion assays. Hep-2 cells were seeded 1 × 10 5 in 24-well plates and incubated at 37°C for 24 h. Bacterial cells were added at a multiplicity of infection (MOI) of 10 to the Hep-2 cells and centrifuged (1,500 r.p.m., 3 min, 20°C), before incubation at 37°C for 1 h. Cells were washed with Dulbecco's phosphate-buffered saline (Sigma-Aldrich) and then incubated for 90 min with DMEM/DMEM-F12 containing 100 µg ml -1 gentamicin. Cells were then washed with PBS and lysed with 1% Triton-X100. Cells were serially diluted and plated onto LB agar to determine c.f.u. counts. In each experiment, three biological replicates were carried out per isolate and the whole experiment was repeated twice. Percentage invasion was calculated by comparing inoculum c.f.u./ml to recovered the c.f.u. after cell lysing.
Background-matched wild-type C57BL/6, Il12 btm1Jm and Ifngr1 tm1Agt (purchased from The Jackson Laboratory) mice (6-14 weeks of age) were bred and maintained in accordance with UK Home Office regulations under project licence 80/2596. This licence was reviewed by The Wellcome Trust Sanger Institute Animal Welfare and Ethical Review Body (AWERB). We carried out a two-tailed analysis of variance to test for statistically significant differences between means in treated mice and to determine 95% confidence intervals. Groups of four to five mice were used, as this is a sufficient sample size given the differences between means and within-group variances we typically observe with these infection models. Mice were inoculated orally by gavage or intravenously with stated amounts of S. Enteritidis suspended in PBS pH 7.4. Although we could not randomize and blind all aspects of the animal experiments, technicians inoculating and checking mice were blinded to the identity of the bacterial strain, and those determining the bacterial numbers by plating were blind to the animal strain. When mice were moribund (less than 80% bodyweight compared with day of inoculation) or on the day post inoculation indicated in the text, mice were euthanized, and the c.f.u.s of each strain in homogenized spleen, liver and heparinized blood was determined by serial dilution in PBS pH 7.4 and plating on LB agar. The human monocyte-like cell line THP-1 was obtained from ECACC (#88081201) and routinely cultured in RPM1 1640 supplemented with 2 mM L-glutamine and 10% heat-inactivated fetal calf serum and tested for mycoplasma. Cells were not further authenticated. Cells were differentiated into mature macrophage-like cells by stimulating with 100 ng ml -1 phorbol 12-myristate 13-acetate (PMA) for 3 days and replaced with medium without PMA for 1 day before assay. Bacteria (strains as indicated) were added to the media at the indicated MOI = 10 and incubated at 37°C for 45 min. After incubation, the medium was replaced with medium containing 100 ng ml -1 gentamicin. At 2 h, the medium was changed to medium containing 10 ng ml -1 gentamicin. At 2 and 4 h post-infection, supernatants were collected and filtered. Supernatants were analysed for cytokine/ chemokine concentrations using the Millipore customized anti-human Milliplex magnetic bead kits as per the manufacturer's instruction. Data were acquired on a Luminex FlexMap3D and analysed with either Luminex or Masterplex QT software. In each experiment, six biological replicates were carried out per isolate and the whole experiment was repeated twice.
Electron microscopy, complement-mediated killing assays and LPS profiling. For electron microscopy, individual colonies were picked directly from an agar plate with a plastic loop and fixed in 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium cacodylate buffer for 1 h at room temperature. The bacteria were then pelleted and briefly rinsed in buffer before fixing in 1% osmium tetroxide, rinsing again and dehydrating in an ethanol series. Pellets were then embedded using an epoxy embedding media kit (Sigma), and 60 μm ultrathin sections were cut on an EM6 ultramicrotome (Leica). Finally, sections were stained with uranyl acetate and lead citrate and imaged on a 120 kV FEI Spirit Biotwin transmission electron microscope with a Tietz F4.15 charge-coupled device camera. For serum bactericidal assays, isolates in log growth were washed twice with PBS and added at a final concentration of 10 6 c.f.u. ml -1 to 100% normal human serum (containing
